SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Loss-Making ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Expected To Breakeven In The Medium-Term [Yahoo! Finance]
NEURELIS ENTERS $208 MILLION AGREEMENT TO MONETIZE INTRAVAIL ROYALTIES [Yahoo! Finance]
ARS Pharmaceuticals Inc (SPRY) Q3 2024 Earnings Call Highlights: Strong Cash Position and NEPHI ... [Yahoo! Finance]
ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024 [Yahoo! Finance]
Form 4 ARS Pharmaceuticals, For: Nov 19 Filed by: Tanimoto Sarina
Form 4 ARS Pharmaceuticals, For: Nov 19 Filed by: Lowenthal Richard E
Form 144 ARS Pharmaceuticals, Filed by: Chakma Justin
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Tanimoto Sarina
Form 4 ARS Pharmaceuticals, For: Nov 12 Filed by: Lowenthal Richard E
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.